Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1571 studies found for:    "Alzheimer disease familial"
Show Display Options
RSS Create an RSS feed from your search for:
"Alzheimer disease familial"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Alzheimer's Disease Genetics Study
Conditions: Alzheimer Disease;   Late Onset Alzheimer Disease;   Dementia
2 Active, not recruiting Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia
Conditions: Alzheimer Disease;   Cognitive Decline Due to Alzheimer Disease;   Mild Cognitive Impairment Due to Alzheimer Disease
Interventions: Drug: Naproxen;   Drug: Placebo
3 Active, not recruiting Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
Conditions: Alzheimers Disease;   Dementia;   Alzheimers Disease, Familial
Interventions: Drug: Gantenerumab;   Drug: Solanezumab;   Drug: Matching Placebo (Gantenerumab);   Drug: Matching Placebo (Solanezumab)
4 Terminated Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
Conditions: Early Onset Alzheimer Disease;   Alzheimer Disease;   Obstructive Sleep Apnea Syndromes
Interventions: Device: CPAP Treatment;   Device: No treatment
5 Completed A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
Conditions: Mild-to-moderate Alzheimer's Disease;   Alzheimer's Disease
Interventions: Drug: SB-742457 15mg;   Drug: SB-742457 35mg;   Drug: Placebo;   Drug: donepezil 5-10mg
6 Completed Alzheimer's Disease Prevention Trial
Conditions: Alzheimer Disease;   Memory Disorders
Interventions: Drug: Estrogen;   Drug: Estrogen and Progesterone
7 Completed Development of NIC5-15 in the Treatment of Alzheimer's Disease
Conditions: Alzheimer Disease;   Dementia
Interventions: Drug: NIC5-15;   Drug: Placebo
8 Completed A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: NIC5-15;   Drug: Placebo
9 Unknown  Far Infrared Treatment for Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
10 Completed Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Condition: Alzheimer's Disease
11 Recruiting Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease;   Prodromal Alzheimer's Disease
Interventions: Drug: Verubecestat (Part I and Part II);   Drug: Placebo (Part I);   Drug: Verubecestat (Part II)
12 Completed Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease
Condition: Alzheimer's Disease
Interventions: Drug: Epigallocatechin-Gallate;   Drug: Placebo
13 Completed
Has Results
Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
14 Completed Alzheimer's Disease: Therapeutic Potential of Estrogen
Condition: Alzheimer Disease
Interventions: Drug: Transdermal estradiol;   Drug: Medroxyprogesterone;   Drug: Placebo Patch;   Drug: Placebo
15 Completed Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 200 mg/day;   Drug: Placebo
16 Completed Memantine for Agitation and Aggression in Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: memantine
17 Active, not recruiting Alzheimer's Disease Neuroimaging Initiative 2
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease (AD);   Significant Memory Concern (SMC);   Early Mild Cognitive Impairment (EMCI);   Late Mild Cognitive Impairment (LMCI)
18 Completed Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 150 mg/day;   Drug: TRx0237 250 mg/day;   Drug: Placebo
19 Unknown  Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease
Conditions: Cognitive Impairment;   Alzheimer Disease
Interventions: Drug: Lithium Carbonate;   Drug: Placebo
20 Completed Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
Condition: Alzheimer Disease
Interventions: Drug: Naproxen Sodium (Aleve);   Drug: Celecoxib (Celebrex)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years